Addressing anti-Blackness in schools, laying the groundwork for cooperation on a COVID-19 vaccine, and new census data on U.S. diversity.
Coordinating the international distribution of medical goods This week, the U.S. Department of Health and Human Services announced that it had purchased nearly the entire supply of Remdesivir—an experimental COVID-19 drug treatment—leaving little for other countries. In an excerpt from Reopening the World, Geoffrey Gertz stresses the importance of international cooperation on the distribution of key medical supplies during the pandemic. Read more | Anti-Blackness and the way forward for K-12 schooling If Americans are serious about addressing the role that anti-Black bias plays in the U.S. education system, efforts to reduce the biases of individual teachers, though very important, are not enough. Francis Pearman writes that to weed out anti-Black bias, the country needs targeted policies toward whole communities designed to counter the full spectrum of insidious, discretionary tendencies that devalue Black life. Read more |
A note on the Brookings response to COVID-19: The Brookings Institution campus in Washington, D.C. will be closed through at least September 7. For more information, read our full guidance here. As Brookings experts continue to assess the global impacts of COVID-19, read the latest analysis and policy recommendations at our coronavirus page or stay up to date with our coronavirus newsletter. | The conclusions and recommendations of any Brookings publication are solely those of its author(s), and do not reflect the views of the Institution, its management, or its other scholars. | |